Just an update on our educational outreach program, SCOPE, where we are providing key information about stem cells in as many languages as possible. If you look at the various pages at the top of this website, you will see “What are stem cells?” in many different languages. In fact, we are now up to […]
No longer lost in translation: stem cells in 9 languages and counting Read More »
Yamanaka may have found a way to give exogenous Myc the boot from the iPS cell universe. It has always been a frustration in the iPS cell field that Myc, a proto-oncogene, is so important for reprogramming. Yes, you can make iPS cells (especially mouse) without Myc, but it can be orders of magnitude harder,
New iPS cell method: drop Myc or not yet? Read More »
Today, I am launching a new effort called Stem Cell Outreach Program for Education (SCOPE). I think stem cell technology will transform medicine across the globe, but it will take a concerted effort to make certain that stem cell-based therapies do not become a type of medicine only available to the relatively wealthy or predominantly available
Launching SCOPE: educating the world about stem cells in their own language Read More »
Ce sunt celulele stem? Organismul uman conţine sute de tipuri diferite de celule care sunt importante pentru sănătatea noastră de zi cu zi. Aceste celule sunt responsabile pentru a păstra funcţia normală a corpului nostru în fiecare zi. Exempluri includ capacitatea de a face inimile noastre sa bată, creierul să creadă, rinichi să curaţe sîngele
Ce sunt celulele stem? Read More »
What really happens to cells after they a stem cell transplant into a patient? Once these cells, which have spent weeks in a lab environment, are injected into a person, what happens next? This is arguably the most important question in the regenerative medicine field, but there are few answers. We are literally mostly in
Stem cells gone wild? What really happens after a transplant Read More »
Last week I posted a stem cell treatment poll. I was curious about people’s experiences and attitudes toward non-FDA approved stem cell treatments. During my time as a stem cell scientist and educator, I have met many people, some of whom have told me about their experiences with stem cell treatments. The results of the
Surprising stem cell treatment poll results Read More »
What are the top stem cell websites and blogs in the world? Who decides? Americans and people all over the world are inexorably changing how they get their information. While newspapers and the nightly news used to spoon-feed us the “top stories” in the news, their heyday is over and now most people get their
A new approach to promoting stem cell research on the Internet Read More »
Yesterday I ran a cancer stem cells meeting here at UC Davis School of Medicine. We had some great speakers and over 150 participants including our outstanding keynote speaker, Dr. Jeremy Rich, Director of Stem Cell Research at the Cleveland Clinic. One of the ideas percolating through the meeting was that during cancer development, there
Cancer stem cells and iPS cells Read More »
Since Yamanaka’s discovery of iPS cells first in mouse and then in human cells 5 years ago, both made using viral transduction, a host of new methods to make iPS cells have been reported. These methods are quite diverse, ranging from transposons, to recombinant proteins, to plasmids, and to RNA. Often times these new
Why miRNA iPS cells might be the ticket: an A+ paper Read More »
CIRM announced two sets of awards today that both should make major impact including its first clinical trial via Geron and $38 million for 27 basic biology studies. First Clinical Trial. Today CIRM awarded $25 million to support Geron’s FDA-approved clinical trial for spinal cord injury. This is CIRM’s first award to a for-profit company
CIRM funds $25 million for Geron trial, $38 million for basic biology Read More »